COMMUNIQUÉS West-GlobeNewswire

Indaptus Therapeutics Chief Scientific Officer Dr. Michael Newman to Present at the Donor Selection & Cell Source Summit
17/11/2025
NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection [...]
NextCure Announces Closing of $21.5 Million PIPE Financing in Advance of First Half 2026 Phase 1 POC Data Readouts
17/11/2025
Extends cash runway into first half of 2027, beyond planned first half of 2026 proof of concept (“POC”) data readouts of SIM0505 (CDH6 ADC) and LNCB74 (B7-H4 ADC) Led by Ikarian Capital, Squadron Capital Management, [...]
T-knife Therapeutics Files Clinical Trial Application for Phase 1 ATLAS Trial for TK-6302, a Supercharged PRAME-targeted T Cell Receptor Therapy
17/11/2025
-- Preclinical data with TK-6302 has shown best-in-class anti-tumor efficacy, demonstrating its potential to elicit deep and durable responses in diverse solid tumor indications with high unmet need -- Following CTA [...]
Curium Consolidates New Biopharma Business and Sets Up Global Headquarters in Boston, Massachusetts
17/11/2025
Curium Biopharma will continue to lead discovery and new product development Strategic move aims to accelerate biopharma innovation and revolutionize the diagnosis and treatment of cancer Curium International [...]
Porosome Therapeutics Publishes Preclinical Findings Demonstrating Restoration of Neuronal Secretion and Reversal of Alzheimer’s Disease Pathology Following Porosome Reconstitution Therapy
17/11/2025
Human brain organoid studies demonstrated significant improvement in neuronal growth, morphology, and function These findings highlight the potential of the porosome – a central node in cellular communication – as a [...]
PetVivo Holdings Announces Digital Landia’s Publication of Technical Whitepaper Validating AgenticPet AI Framework Under Exclusive 10-Year Licensing Agreement
17/11/2025
Comprehensive Documentation Confirms Production-Ready Architecture for PetVivo’s Veterinary Platform Launching Q1 2026 MINNEAPOLIS, Nov. 17, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX: PETV; OTCID: PETVW), [...]
Autonomix Medical, Inc. Reports Positive Subgroup Results Demonstrating Sustained Improvements in Quality of Life from Post Hoc Analysis of Pancreatic Cancer PoC Study
17/11/2025
EORTC QLQ-C30 subgroup results confirm broad and durable quality-of-life improvements across disease stages and metastasis status, complementing previously reported pain reduction and opioid-free outcomes Late-stage [...]
ProPhase Labs Urges Shareholders to Vote by November 23 on Proxy Proposals
17/11/2025
UNIONDALE, NY, Nov. 17, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) reminds shareholders of record as of October 20, 2025, of the Company's upcoming Special Meeting of Stockholders, which will be held on [...]
Protara Therapeutics to Present New Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in BCG-Naïve NMIBC Patients at the 26th Annual Meeting of the Society of Urologic Oncology
17/11/2025
NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that [...]
Radiopharm Theranostics Announces 50% Enrollment in Phase 2b Clinical Trial of RAD101 Imaging in Brain Metastases
17/11/2025
Early patient data from Phase 2b clinical trial showed significant and selective tumor uptake in brain metastases compared to MRI Phase 2b clinical trial expected to complete enrollment and have topline data in 1H26 [...]
Cerevance to Participate in the TD Cowen Treatment Advancements in Obesity and Related Disorders Summit
17/11/2025
BOSTON, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Cerevance, a clinical-stage biopharmaceutical company advancing multiple cell type-specific therapies for the treatment of neurodegenerative diseases and obesity, today [...]
Grace Therapeutics to Participate in 16th Annual Craig-Hallum Alpha Select Conference
17/11/2025
PRINCETON, N.J., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Grace Therapeutics, Inc. (Nasdaq: GRCE) (Grace Therapeutics or the Company), a late-stage, biopharma company advancing GTx-104, a clinical-stage, novel, injectable [...]
Communiqué de presse : Sanofi réaffirme son engagement à innover depuis la France pour le monde
17/11/2025
Choose France – Édition France 2025 Sanofi réaffirme son engagement à innover depuis la France pour le monde Paris, 17 novembre 2025. À l'occasion du premier sommet Choose France dédié aux entreprises françaises, Sanofi [...]
Zelluna ASA: New share capital registered
17/11/2025
Oslo, Norway, 17 November, 2025: Reference is made to the stock exchange announcement made by Zelluna ASA (the "Company") on 3 November 2025 regarding the successful private placement of 5,500,000 new shares (the " [...]
Ramsay Sante : conditions of availability and consultation of the preparatory documents for the Ramsay Générale de Santé General Meeting of December 11, 2025
17/11/2025
PRESS RELEASE Paris, 14 th November 2025 COMBINED GENERAL MEETING OF DECEMBER 11, 2025 Conditions of availability and consultation of the preparatory documents for the Ramsay Générale de Santé General Meeting of [...]
RAMSAY SANTE : modalités de mise à disposition ou de consultation des documents préparatoires à l'Assemblée générale de Ramsay Générale de Santé du 11 décembre 2025
17/11/2025
COMMUNIQUÉ DE PRESSE Paris, le 14 novembre 2025 ASSEMBLEE GENERALE MIXTE DU 11 DECEMBRE 2025 Modalités de mise à disposition ou de consultation des documents préparatoires à l’Assemblée générale de Ramsay Générale de [...]
Clue Expands Wearable Integrations with Withings, Ultrahuman, WHOOP, Huawei, Polar, Fitbit, Noise and Luna, Unlocking Deeper Insights into Women’s Health
17/11/2025
LONDON, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Clue , the #1 women-led period and cycle tracker trusted by over 100 million worldwide, has today announced expanded integrations with leading wearable partners Withings , [...]
Nxera Pharma Shares Video Interviews with Major Shareholders on Its Official YouTube Channel
17/11/2025
Perspectives from Nxera’s major shareholders provide deeper insights into their investment views and confidence in the Company’s strategy Tokyo, Japan and Cambridge and London, UK, 17 November 2025 – Nxera Pharma Co., [...]
Inventiva announces full exercise of Underwriters’ Option, bringing proceeds of Offering to approximately $172.5M
17/11/2025
Daix (France), New York City (New York, United States), November 17, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (" Inventiva " or the " Company "), a clinical-stage biopharmaceutical company focused on the [...]

Pages